FGF23 and kidney disorder: Increased circulating FGF23 concentrations are associated with LVH, kidney disease progression, and mortality in patients with dialysis, predialysis CKD, or non-CKD, independent of risk factors, such as high phosphate and parathyroid hormone concentrations (8–14).